Basic Information
ID: ALA4404535
Type: Functional
Description: Antiviral activity against Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation at 10 uM incubated for 7 days by GFP reporter gene assay relative to control
Organism: Human adenovirus 5
Activity Charts
Bioactivity
Activity Types for Assay ALA4404535
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 327.12 | 3.86 | 3.86 |
| 383.68 | 5.34 | 5.34 |
| 261.71 | 2.98 | 2.98 |
| 292.68 | 3.21 | 3.21 |
| 350.12 | 4.97 | 4.97 |
| 310.67 | 3.35 | 3.35 |
| 283.66 | 3.58 | 3.58 |
| 275.74 | 3.54 | 3.54 |
| 329.70 | 3.99 | 3.99 |
| 449.26 | 5.11 | 5.11 |
| 503.36 | 3.67 | 3.67 |
| 482.81 | 5.48 | 5.48 |
| 551.41 | 4.25 | 4.25 |
| 299.22 | 3.80 | 3.80 |
| 426.26 | 4.00 | 4.00 |
| 317.67 | 4.75 | 4.75 |
| 333.67 | 4.46 | 4.46 |
| 347.69 | 4.13 | 4.13 |
| 347.69 | 4.13 | 4.13 |
| 307.75 | 3.85 | 3.85 |
| 474.30 | 4.59 | 4.59 |
| 306.71 | 2.88 | 2.88 |
| 293.73 | 3.16 | 3.16 |
| 297.69 | 3.25 | 3.25 |
| 432.80 | 4.60 | 4.60 |
| 440.28 | 4.39 | 4.39 |
| 313.25 | 4.11 | 4.11 |
| 275.74 | 3.54 | 3.54 |
| 341.15 | 3.79 | 3.79 |
| 347.69 | 4.13 | 4.13 |
| 458.32 | 4.10 | 4.10 |
| 330.60 | 4.28 | 4.28 |
| 296.15 | 3.63 | 3.63 |
| 310.18 | 4.19 | 4.19 |
| 461.28 | 2.64 | 2.64 |
| 530.85 | 6.06 | 6.06 |
| 333.67 | 4.46 | 4.46 |
| 314.14 | 3.77 | 3.77 |
| 327.12 | 3.86 | 3.86 |
| 440.28 | 4.39 | 4.39 |
| 382.79 | 3.72 | 3.72 |
| 341.15 | 3.54 | 3.54 |
| 305.76 | 3.55 | 3.55 |
| 293.73 | 3.68 | 3.68 |
| 474.30 | 4.59 | 4.59 |
| 512.35 | 4.47 | 4.47 |
| 384.18 | 2.98 | 2.98 |
| 297.69 | 3.25 | 3.25 |
| 279.70 | 3.11 | 3.11 |
| 310.67 | 3.35 | 3.35 |
| 398.20 | 3.36 | 3.36 |
| 275.74 | 3.28 | 3.28 |
| 296.15 | 3.63 | 3.63 |
| 293.73 | 3.46 | 3.46 |
| 347.69 | 4.38 | 4.38 |